NasdaqGS:KRYSBiotechs
Krystal Biotech (KRYS) Valuation Check As Shares Trade Near Suggested 5.2% Discount To Fair Value
Krystal Biotech (KRYS) has drawn fresh attention after recent share price moves, with the stock showing a mix of gains over the past month and year and some softness over the past 3 months.
See our latest analysis for Krystal Biotech.
The recent 10.34% 1 month share price return alongside an 11.76% year to date share price gain contrasts with a softer 4.56% 3 month share price return. At the same time, the 66.43% 1 year total shareholder return points to momentum that has been building over a...